Varex director sells 8,121 shares at $18.48

Varex Imaging Corp (VREX) director Jay K. Kunkel reported selling 8,121 shares of common stock on September 14, 2026 at $18.48 per share in an open-market or private transaction.

Rhea-AI Filing Summary

Varex Imaging Corp (VREX) director Jay K. Kunkel reported selling 8,121 shares of common stock on September 14, 2026 at $18.48 per share in an open-market or private transaction. After this sale, he directly holds 15,329 shares of Varex Imaging Corp, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Net Seller: 8,121 shares

Net Sell 1 txn

Insider Kunkel Jay K.

Role Director

Sold 8,121 shs ($150K)

Type	Security	Shares	Price	Value
Sale	Common Stock	8,121	$18.48	$150K

Holdings After Transaction: Common Stock — 15,329 shares (Direct)

Key Figures

Shares sold: 8,121 shares Sale price per share: $18.48 per share Shares held after transaction: 15,329 shares

3 metrics

Shares sold 8,121 shares Common stock sale reported for September 14, 2026

Sale price per share $18.48 per share Price for the 8,121 common shares sold on September 14, 2026

Shares held after transaction 15,329 shares Direct holdings of Jay K. Kunkel following the sale

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Varex Imaging Corp (VREX) report for Jay K. Kunkel?

Varex Imaging Corp reported that director Jay K. Kunkel sold 8,121 shares of common stock on September 14, 2026 in an open-market or private transaction at $18.48 per share.

How many VREX shares does Jay K. Kunkel hold after this Form 4 transaction?

After the reported sale, Jay K. Kunkel directly holds 15,329 shares of Varex Imaging Corp common stock. This figure reflects his position immediately following the September 14, 2026 transaction disclosed.

Was Jay K. Kunkel’s VREX stock sale made under a Rule 10b5-1 trading plan?

No. The filing indicates that the transaction was not made under a Rule 10b5-1 trading plan, as the related affirmation box is unchecked and no plan information is referenced in the notes.

What was the sale price per share in Jay K. Kunkel’s VREX stock transaction?

The reported sale price was $18.48 per share for the 8,121 Varex Imaging Corp common shares sold on September 14, 2026. The price is stated on a per-share basis.

What role does Jay K. Kunkel have at Varex Imaging Corp (VREX) in this Form 4?

In this Form 4, Jay K. Kunkel is identified as a director of Varex Imaging Corp. He is not listed as an officer or a ten percent owner in the reporting information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 05:45 PM Accepted by SEC EDGAR 09/15/2026 - 05:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kunkel Jay K.

(Last) (First) (Middle)

C/O VAREX IMAGING CORP

1678 S. PIONEER ROAD

(Street)

SALT LAKE CITY UTAH 84104

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Varex Imaging Corp [ VREX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/14/2026		S		8,121	D	$18.48	15,329	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Richard T. Ludlow, attorney-in-fact- for Jay K. Kunkel	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)